Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

Status:
Completed

Trial end date:
2019-08-14

Target enrollment:

Participant gender:

This is a randomized double-blind/placebo study evaluate the efficacy of ASN002 in subjects with moderate to severe atopic dermatitis (AD).

Phase 2

Asana BioSciences